только для медицинских специалистов

Консультант врача

Электронная медицинская библиотека

Раздел 11 / 22
Страница 1 / 1

Список литературы

  1. Jauniaux E. et al. Placenta Praevia and Placenta Accreta: Diagnosis and Management // BJOG An Int. J. Obstet. Gynaecol. 2019. Vol. 126, № 1. P. e1–e48.
  2. De Mucio B. et al. A systematic review and meta‐analysis of cesarean delivery and other uterine surgery as risk factors for placenta accreta // Int. J. Gynecol. Obstet. 2019. Vol. 147, № 3. P. 281–291.
  3. Chen Y. et al. Persistent hypoxia induced autophagy leading to invasiveness of trophoblasts in placenta accreta. // J. Matern. Fetal. Neonatal Med. 2021. Vol. 34, № 8. P. 1297–1303.
  4. Timor-Tritsch I.E. et al. Cesarean scar pregnancy and early placenta accreta share common histology. // Ultrasound Obstet. Gynecol. 2014. Vol. 43, № 4. P. 383–395.
  5. Society of Gynecologic Oncology et al. Placenta Accreta Spectrum. // Am. J. Obstet. Gynecol. 2018. Vol. 219, № 6. P. B2–B16.
  6. Jauniaux E., Bhide A. Prenatal ultrasound diagnosis and outcome of placenta previa accreta after cesarean delivery: a systematic review and meta-analysis. // Am. J. Obstet. Gynecol. 2017. Vol. 217, № 1. P. 27–36.
  7. Morlando M. et al. Reproductive outcome after cesarean scar pregnancy: A systematic review and meta-analysis. // Acta Obstet. Gynecol. Scand. 2020. Vol. 99, № 10. P. 1278–1289.
  8. Jauniaux E. et al. Epidemiology of placenta previa accreta: a systematic review and metaanalysis. // BMJ Open. 2019. Vol. 9, № 11. P. e031193.
  9. Martimucci K. et al. Interpregnancy interval and abnormally invasive placentation. // Acta Obstet. Gynecol. Scand. 2019. Vol. 98, № 2. P. 183–187.
  10. Castaneda S., Karrison T., Cibils L.A. Peripartum hysterectomy. // J. Perinat. Med. 2000. Vol. 28, № 6. P. 472–481.
  11. Iacovelli A. et al. Risk factors for abnormally invasive placenta: a systematic review and metaanalysis. // J. Matern. Fetal. Neonatal Med. 2020. Vol. 33, № 3. P. 471–481.
  12. Fitzpatrick K.E. et al. Incidence and risk factors for placenta accreta/increta/percreta in the UK: a national case-control study. // PLoS One. 2012. Vol. 7, № 12. P. e52893.
  13. Calì G. et al. Outcome of Cesarean scar pregnancy managed expectantly: systematic review and meta‐analysis // Ultrasound Obstet. Gynecol. 2018. Vol. 51, № 2. P. 169–175.
  14. Kohn J.R. et al. Pregnancy after endometrial ablation: a systematic review. // BJOG. 2018. Vol. 125, № 1. P. 43–53.
  15. Read J.A., Cotton D.B., Miller F.C. Placenta accreta: changing clinical aspects and outcome. // Obstet. Gynecol. 1980. Vol. 56, № 1. P. 31–34.
  16. Wu S., Kocherginsky M., Hibbard J.U. Abnormal placentation: twenty-year analysis. // Am. J. Obstet. Gynecol. 2005. Vol. 192, № 5. P. 1458–1461.
  17. Amin M.B. et al. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. // CA. Cancer J. Clin. 2017. Vol. 67, № 2. P. 93–99.
  18. Federal State Statistics Service (Rosstat). Russian Statistical Yearbook. 2019. 694 p.
  19. Neilson J.P. Interventions for suspected placenta praevia. // Cochrane database Syst. Rev. 2003. № 2. P. CD001998.
  20. Erm Jauniaux,Z Alfirevic,A G Bhide,M A Belfort,G J Burton,S L Collins,S Dornan,D Jurkovic,G Kayem,J Kingdom,R Silver L.S. Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green-top Guideline No. 27a // BJOG An Int. J. Obstet. Gynaecol. 2018.
  21. Jauniaux E. et al. FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders. // Int. J. Gynaecol. Obstet. 2019. Vol. 146, № 1. P. 20–24.
  22. Palacios-Jaraquemada J.M. et al. Systematic review on near miss cases of placenta accreta spectrum disorders: correlation with invasion topography, prenatal imaging, and surgical outcome. // J. Matern. Fetal. Neonatal Med. 2020. Vol. 33, № 19. P. 3377–3384.
  23. Expert Panel on Women’s Imaging et al. ACR Appropriateness Criteria® Placenta Accreta Spectrum Disorder. // J. Am. Coll. Radiol. 2020. Vol. 17, № 5S. P. S207–S214.
  24. Savelieva G.M. et al. [Development and practical implementation of organ preservation surgery in case of placenta accreta in patients with a scar on the uterus]. // Probl. sotsial’noi Gig. Zdr. i Istor. meditsiny. 2019. Vol. 27, № Special Issue. P. 693–698.
  25. D’Antonio F. et al. First-trimester detection of abnormally invasive placenta in high-risk women: systematic review and meta-analysis. // Ultrasound Obstet. Gynecol. 2018. Vol. 51, № 2. P. 176– 183.
  26. Panaiotova J. et al. Screening for morbidly adherent placenta in early pregnancy. // Ultrasound Obstet. Gynecol. 2019. Vol. 53, № 1. P. 101–106.
  27. Hobson S.R. et al. No. 383-Screening, Diagnosis, and Management of Placenta Accreta Spectrum Disorders. // J. Obstet. Gynaecol. Can. 2019. Vol. 41, № 7. P. 1035–1049.
  28. Melcer Y. et al. Impact of targeted scanning protocols on perinatal outcomes in pregnancies at risk of placenta accreta spectrum or vasa previa. // Am. J. Obstet. Gynecol. 2018. Vol. 218, № 4. P. 443.e1-443.e8.
  29. D’Antonio F., Iacovella C., Bhide A. Prenatal identification of invasive placentation using ultrasound: systematic review and meta-analysis. // Ultrasound Obstet. Gynecol. 2013. Vol. 42, № 5. P. 509–517.
  30. Buca D. et al. Influence of prenatal diagnosis of abnormally invasive placenta on maternal outcome: systematic review and meta-analysis. // Ultrasound Obstet. Gynecol. 2018. Vol. 52, № 3. P. 304–309.
  31. Collins S.L. et al. Proposal for standardized ultrasound descriptors of abnormally invasive placenta (AIP). // Ultrasound Obstet. Gynecol. 2016. Vol. 47, № 3. P. 271–275.
  32. Jauniaux E. et al. FIGO consensus guidelines on placenta accreta spectrum disorders: Prenatal diagnosis and screening. // Int. J. Gynaecol. Obstet. 2018. Vol. 140, № 3. P. 274–280.
  33. Alfirevic Z. et al. Pro forma for ultrasound reporting in suspected abnormally invasive placenta (AIP): an international consensus. // Ultrasound Obstet. Gynecol. 2016. Vol. 47, № 3. P. 276– 278.
  34. D’Antonio F. et al. Prenatal identification of invasive placentation using magnetic resonance imaging: systematic review and meta-analysis. // Ultrasound Obstet. Gynecol. 2014. Vol. 44, № 1. P. 8–16.
  35. Familiari A. et al. Diagnostic accuracy of magnetic resonance imaging in detecting the severity of abnormal invasive placenta: a systematic review and meta-analysis. // Acta Obstet. Gynecol. Scand. 2018. Vol. 97, № 5. P. 507–520.
  36. Poder L. et al. ACR Appropriateness Criteria® Placenta Accreta Spectrum Disorder // J. Am. Coll. Radiol. 2020. Vol. 17, № 5. P. S207–S214.
  37. Jha P. et al. Society of Abdominal Radiology (SAR) and European Society of Urogenital Radiology (ESUR) joint consensus statement for MR imaging of placenta accreta spectrum disorders. // Eur. Radiol. 2020. Vol. 30, № 5. P. 2604–2615.
  38. Hecht J.L. et al. Classification and reporting guidelines for the pathology diagnosis of placenta accreta spectrum (PAS) disorders: recommendations from an expert panel. // Mod. Pathol. 2020. Vol. 33, № 12. P. 2382–2396.
  39. Wing D.A., Paul R.H., Millar L.K. Management of the symptomatic placenta previa: a randomized, controlled trial of inpatient versus outpatient expectant management. // Am. J. Obstet. Gynecol. 1996. Vol. 175, № 4 Pt 1. P. 806–811.
  40. Publications Committee S. for M.-F.M., Belfort M.A. Placenta accreta. // Am. J. Obstet. Gynecol. 2010. Vol. 203, № 5. P. 430–439.
  41. Rac M.W.F. et al. Placenta accreta and vaginal bleeding according to gestational age at delivery. // Obstet. Gynecol. 2015. Vol. 125, № 4. P. 808–813.
  42. Bowman Z.S. et al. Risk factors for unscheduled delivery in patients with placenta accreta. // Am. J. Obstet. Gynecol. 2014. Vol. 210, № 3. P. 241.e1-6.
  43. Fishman S.G., Chasen S.T. Risk factors for emergent preterm delivery in women with placenta previa and ultrasound findings suspicious for placenta accreta. // J. Perinat. Med. 2011. Vol. 39, № 6. P. 693–696.
  44. Pri-Paz S. et al. Comparison between emergent and elective delivery in women with placenta accreta. // J. Matern. Fetal. Neonatal Med. 2013. Vol. 26, № 10. P. 1007–1011.
  45. Warshak C.R. et al. Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta. // Obstet. Gynecol. 2010. Vol. 115, № 1. P. 65–69.
  46. Robinson B.K., Grobman W.A. Effectiveness of timing strategies for delivery of individuals with placenta previa and accreta. // Obstet. Gynecol. 2010. Vol. 116, № 4. P. 835–842.
  47. Seoud M.A. et al. Placenta accreta: Elective versus emergent delivery as a major predictor of blood loss. // J. Neonatal. Perinatal. Med. 2017. Vol. 10, № 1. P. 9–15.
  48. Angstmann T. et al. Surgical management of placenta accreta: a cohort series and suggested approach. // Am. J. Obstet. Gynecol. 2010. Vol. 202, № 1. P. 38.e1-9.
  49. Collins S.L. et al. Evidence-based guidelines for the management of abnormally invasive placenta: recommendations from the International Society for Abnormally Invasive Placenta. // Am. J. Obstet. Gynecol. 2019. Vol. 220, № 6. P. 511–526.
  50. Eller A.G. et al. Optimal management strategies for placenta accreta. // BJOG. 2009. Vol. 116, № 5. P. 648–654.
  51. Jauniaux E. et al. Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green-top Guideline No. 27a. // BJOG. 2019. Vol. 126, № 1. P. e1–e48.
  52. Taylor N.J., Russell R. Anaesthesia for abnormally invasive placenta: a single-institution case series. // Int. J. Obstet. Anesth. 2017. Vol. 30. P. 10–15.
  53. Курцер М.А. et al. Placenta accreta // Obstet. Gynecol. 2002. Vol. 99, № 1. P. 169–170.
  54. Nguyen-Lu N. et al. Mode of anesthesia and clinical outcomes of patients undergoing Cesarean delivery for invasive placentation: a retrospective cohort study of 50 consecutive cases. // Can. J. Anaesth. 2016. Vol. 63, № 11. P. 1233–1244.
  55. Khokhar R. et al. Placenta accreta and anesthesia: A multidisciplinary approach // Saudi J. Anaesth. 2016. Vol. 10, № 3. P. 332.
  56. Kocaoglu N. et al. Management of anesthesia for cesarean section in parturients with placenta previa with/without placenta accreta: a retrospective study. // Ginekol. Pol. 2012. Vol. 83, № 2. P. 99–103.
  57. Nguyen-Lu N. et al. Mode of anesthesia and clinical outcomes of patients undergoing Cesarean delivery for invasive placentation: a retrospective cohort study of 50 consecutive cases // Can. J. Anesth. Can. d’anesthésie. 2016. Vol. 63, № 11. P. 1233–1244.
  58. Markley J.C. et al. Neuraxial Anesthesia During Cesarean Delivery for Placenta Previa With Suspected Morbidly Adherent Placenta: A Retrospective Analysis. // Anesth. Analg. 2018. Vol. 127, № 4. P. 930–938.
  59. Schmidt G.A. et al. Liberation From Mechanical Ventilation in Critically Ill Adults: Executive Summary of an Official American College of Chest Physicians/American Thoracic Society Clinical Practice Guideline // Chest. 2017. Vol. 151, № 1. P. 160–165.
  60. Muñoz M. et al. Patient blood management in obstetrics: prevention and treatment of postpartum haemorrhage. A NATA consensus statement. // Blood Transfus. 2019. Vol. 17, № 2. P. 112–136.
  61. Spruit M.A. et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. // Am. J. Respir. Crit. Care Med. 2013. Vol. 188, № 8. P. e13-64.
  62. Smulian J.C. et al. Invasive placental disease: the impact of a multi-disciplinary team approach to management. // J. Matern. Fetal. Neonatal Med. 2017. Vol. 30, № 12. P. 1423–1427.
  63. Al-Khan A. et al. Maternal and Fetal Outcomes in Placenta Accreta After Institution of TeamManaged Care // Reprod. Sci. 2014. Vol. 21, № 6. P. 761–771.
  64. Eller A.G. et al. Maternal Morbidity in Cases of Placenta Accreta Managed by a Multidisciplinary Care Team Compared With Standard Obstetric Care // Obstet. Gynecol. 2011. Vol. 117, № 2. P. 331–337.
  65. Shamshirsaz A.A. et al. Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach. // Am. J. Obstet. Gynecol. 2015. Vol. 212, № 2. P. 218.e1-9.
  66. Silver R.M. et al. Center of excellence for placenta accreta. // Am. J. Obstet. Gynecol. 2015. Vol. 212, № 5. P. 561–568.
  67. Shamshirsaz A.A. et al. Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach // Am. J. Obstet. Gynecol. 2015. Vol. 212, № 2. P. 218.e1-218.e9.
  68. Singh S.S. et al. Surgical safety checklist in obstetrics and gynaecology. // J. Obstet. Gynaecol. Can. 2013. Vol. 35, № 1. P. 82–85.
  69. Palacios-Jaraquemada J.M. et al. Placenta accreta spectrum: a hysterectomy can be prevented in almost 80% of cases using a resective-reconstructive technique. // J. Matern. Fetal. Neonatal Med. 2020. P. 1–8.
  70. Kotsuji F. et al. Transverse uterine fundal incision for placenta praevia with accreta, involving the entire anterior uterine wall: a case series. // BJOG. 2013. Vol. 120, № 9. P. 1144–1149.
  71. Shmakov R.G. et al. Conservative Surgery in Abnormal Placenta Invasion (5-year Experience of V.I. Kulakov National Medical Scientific Centre of Obstetrics, Gynaecology and Perinatal Medicine) // Doctor.Ru. 2019. Vol. 166, № 11. P. 29–34.
  72. Shmakov R.G. et al. Alternative approaches to surgical hemostasis in patients with morbidly adherent placenta undergoing fertility-sparing surgery // J. Matern. Neonatal Med. 2019. Vol. 32, № 12. P. 2042–2048.
  73. Teixidor Viñas M. et al. Prevention of postpartum hemorrhage and hysterectomy in patients with morbidly adherent placenta: a cohort study comparing outcomes before and after introduction of the Triple-P procedure. // Ultrasound Obstet. Gynecol. 2015. Vol. 46, № 3. P. 350–355.
  74. Alanis M. et al. Conservative management of placenta increta with selective arterial embolization preserves future fertility and results in a favorable outcome in subsequent pregnancies. // Fertil. Steril. 2006. Vol. 86, № 5. P. 1514.e3-7.
  75. Clausen C., Lönn L., Langhoff-Roos J. Management of placenta percreta: a review of published cases. // Acta Obstet. Gynecol. Scand. 2014. Vol. 93, № 2. P. 138–143.
  76. Kilicci C. et al. Planned cesarean hysterectomy versus modified form of segmental resection in patients with placenta percreta. // J. Matern. Fetal. Neonatal Med. 2018. Vol. 31, № 22. P. 2935– 2940.
  77. Clark S.L. et al. Hypogastric artery ligation for obstetric hemorrhage. // Obstet. Gynecol. 1985. Vol. 66, № 3. P. 353–356.
  78. Shahin A.Y. et al. Bilateral uterine artery ligation plus B-Lynch procedure for atonic postpartum hemorrhage with placenta accreta. // Int. J. Gynaecol. Obstet. 2010. Vol. 108, № 3. P. 187–190.
  79. Hwu Y.-M. et al. Parallel vertical compression sutures: a technique to control bleeding from placenta praevia or accreta during caesarean section. // BJOG. 2005. Vol. 112, № 10. P. 1420– 1423.
  80. Mei J. et al. Systematic review of uterus-preserving treatment modalities for abnormally invasive placenta. // J. Obstet. Gynaecol. 2015. Vol. 35, № 8. P. 777–782.
  81. Pan Y. et al. Retrospective cohort study of prophylactic intraoperative uterine artery embolization for abnormally invasive placenta. // Int. J. Gynaecol. Obstet. 2017. Vol. 137, № 1. P. 45–50.
  82. Hussein A.M. et al. The role of prophylactic internal iliac artery ligation in abnormally invasive placenta undergoing caesarean hysterectomy: a randomized control trial. // J. Matern. Fetal. Neonatal Med. 2019. Vol. 32, № 20. P. 3386–3392.
  83. Salim R. et al. Precesarean Prophylactic Balloon Catheters for Suspected Placenta Accreta: A Randomized Controlled Trial. // Obstet. Gynecol. 2015. Vol. 126, № 5. P. 1022–1028.
  84. Camuzcuoglu A. et al. Surgical management of 58 patients with placenta praevia percreta. // Wien. Klin. Wochenschr. 2016. Vol. 128, № 9–10. P. 360–366.
  85. Kayem G., Keita H. [Management of placenta previa and accreta]. // J. Gynecol. Obstet. Biol. Reprod. (Paris). 2014. Vol. 43, № 10. P. 1142–1160.
  86. De Mucio B. et al. A systematic review and meta-analysis of cesarean delivery and other uterine surgery as risk factors for placenta accreta. // Int. J. Gynaecol. Obstet. 2019. Vol. 147, № 3. P. 281–291.
  87. Pather S. et al. Maternal outcome after conservative management of placenta percreta at caesarean section: a report of three cases and a review of the literature. // Aust. N. Z. J. Obstet. Gynaecol. 2014. Vol. 54, № 1. P. 84–87.
  88. Timmermans S., van Hof A.C., Duvekot J.J. Conservative management of abnormally invasive placentation. // Obstet. Gynecol. Surv. 2007. Vol. 62, № 8. P. 529–539.
  89. Manzano Nunez R. et al. A meta-analysis of resuscitative endovascular balloon occlusion of the aorta (REBOA) or open aortic cross-clamping by resuscitative thoracotomy in non-compressible torso hemorrhage patients. // World J. Emerg. Surg. 2017. Vol. 12. P. 30.
  90. Chen L. et al. Clinical evaluation of prophylactic abdominal aortic balloon occlusion in patients with placenta accreta: a systematic review and meta-analysis. // BMC Pregnancy Childbirth. 2019. Vol. 19, № 1. P. 30.
  91. Chu Q. et al. Anesthetic management of cesarean section in cases of placenta accreta, with versus without abdominal aortic balloon occlusion: study protocol for a randomized controlled trial. // Trials. 2017. Vol. 18, № 1. P. 240.
  92. Yu S.C.H. et al. Perioperative prophylactic internal iliac artery balloon occlusion in the prevention of postpartum hemorrhage in placenta previa: a randomized controlled trial. // Am. J. Obstet. Gynecol. 2020. Vol. 223, № 1. P. 117.e1-117.e13.
  93. Wei Y. et al. Evaluation of a modified “Triple-P” procedure in women with morbidly adherent placenta after previous caesarean section // Arch. Gynecol. Obstet. 2017. Vol. 296, № 4. P. 737– 743.
  94. Dai Y.M. et al. [Intrauterine balloon tamponade combined with temporary abdominal aortic balloon occlusion in the management of women with placenta accreta spectrum:a randomized controlled trial]. // Zhonghua Fu Chan Ke Za Zhi. 2020. Vol. 55, № 7. P. 450–456.
  95. Suarez S. et al. Uterine balloon tamponade for the treatment of postpartum hemorrhage: a systematic review and meta-analysis. // Am. J. Obstet. Gynecol. 2020. Vol. 222, № 4. P. 293.e1293.e52.
  96. Wei J. et al. Intrauterine double-balloon tamponade vs gauze packing in the management of placenta previa: A multicentre randomized controlled trial. // Medicine (Baltimore). 2020. Vol. 99, № 7. P. e19221.
  97. Робер Д. et al. Клиническое практическое руководство ассоциации акушеров-гинекологов Канады ( SOGC ): диагностика и ведение предлежания плаценты ( placenta previa ). P. 77– 84.

Для продолжения работы требуется вход / регистрация